{"frames":[{"target":{"name":"Text","spans":[{"start":0,"end":1,"text":"Journal"}]},"annotationSets":[{"rank":0,"score":62.81056516604094,"frameElements":[{"name":"Text","spans":[{"start":0,"end":1,"text":"Journal"}]}]}]},{"target":{"name":"Scrutiny","spans":[{"start":3,"end":4,"text":"investigation"}]},"annotationSets":[{"rank":0,"score":50.38433953152557,"frameElements":[]}]}],"tokens":["Journal","of","clinical","investigation","."]}
{"frames":[{"target":{"name":"Medical_conditions","spans":[{"start":0,"end":1,"text":"Tumor"}]},"annotationSets":[{"rank":0,"score":31.855831856175907,"frameElements":[]}]},{"target":{"name":"Predicting","spans":[{"start":3,"end":4,"text":"predicts"}]},"annotationSets":[{"rank":0,"score":37.441899173288405,"frameElements":[{"name":"Eventuality","spans":[{"start":4,"end":11,"text":"response to anti-PD-1 therapy in human melanoma"}]},{"name":"Speaker","spans":[{"start":0,"end":3,"text":"Tumor immune profiling"}]}]}]},{"target":{"name":"Response","spans":[{"start":4,"end":5,"text":"response"}]},"annotationSets":[{"rank":0,"score":44.33929397992582,"frameElements":[{"name":"Trigger","spans":[{"start":5,"end":11,"text":"to anti-PD-1 therapy in human melanoma"}]}]}]},{"target":{"name":"Cure","spans":[{"start":7,"end":8,"text":"therapy"}]},"annotationSets":[{"rank":0,"score":42.52839528682138,"frameElements":[]}]},{"target":{"name":"People","spans":[{"start":9,"end":10,"text":"human"}]},"annotationSets":[{"rank":0,"score":35.40951270922699,"frameElements":[{"name":"Person","spans":[{"start":9,"end":10,"text":"human"}]}]}]}],"tokens":["Tumor","immune","profiling","predicts","response","to","anti-PD-1","therapy","in","human","melanoma","."]}
{"frames":[],"tokens":["BACKGROUND","."]}
{"frames":[{"target":{"name":"Cure","spans":[{"start":5,"end":6,"text":"therapy"}]},"annotationSets":[{"rank":0,"score":41.967793811671896,"frameElements":[]}]},{"target":{"name":"Stage_of_progress","spans":[{"start":7,"end":8,"text":"advanced"}]},"annotationSets":[{"rank":0,"score":8.239464485379422,"frameElements":[{"name":"Entity","spans":[{"start":8,"end":9,"text":"cancer"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":8,"end":9,"text":"cancer"}]},"annotationSets":[{"rank":0,"score":34.79198701263016,"frameElements":[]}]},{"target":{"name":"Quantity","spans":[{"start":11,"end":12,"text":"many"}]},"annotationSets":[{"rank":0,"score":29.82818981450002,"frameElements":[{"name":"Quantity","spans":[{"start":11,"end":12,"text":"many"}]},{"name":"Individuals","spans":[{"start":12,"end":13,"text":"patients"}]}]}]},{"target":{"name":"Intentionally_act","spans":[{"start":13,"end":14,"text":"do"}]},"annotationSets":[{"rank":0,"score":50.91399943868855,"frameElements":[{"name":"Agent","spans":[{"start":11,"end":13,"text":"many patients"}]}]}]},{"target":{"name":"Response","spans":[{"start":15,"end":16,"text":"respond"}]},"annotationSets":[{"rank":0,"score":39.804473821969125,"frameElements":[{"name":"Agent","spans":[{"start":12,"end":13,"text":"patients"}]},{"name":"Trigger","spans":[{"start":16,"end":18,"text":"to treatment"}]}]}]},{"target":{"name":"Cure","spans":[{"start":17,"end":18,"text":"treatment"}]},"annotationSets":[{"rank":0,"score":47.05602779734238,"frameElements":[]}]}],"tokens":["Immune","checkpoint","blockade","is","revolutionizing","therapy","for","advanced","cancer",",","but","many","patients","do","not","respond","to","treatment","."]}
{"frames":[{"target":{"name":"Purpose","spans":[{"start":15,"end":17,"text":"in order"}]},"annotationSets":[{"rank":0,"score":30.86391146282162,"frameElements":[{"name":"Goal","spans":[{"start":17,"end":18,"text":"to"}]}]}]},{"target":{"name":"Expectation","spans":[{"start":6,"end":7,"text":"predict"}]},"annotationSets":[{"rank":0,"score":32.342903892402205,"frameElements":[{"name":"Cognizer","spans":[{"start":5,"end":6,"text":"that"}]},{"name":"Phenomenon","spans":[{"start":7,"end":35,"text":"clinical response to specific checkpoint inhibitors is critical in order to stratify patients and to rationally select combinations in the context of an expanding array of therapeutic options"}]}]}]},{"target":{"name":"Response","spans":[{"start":8,"end":9,"text":"response"}]},"annotationSets":[{"rank":0,"score":46.7189492045796,"frameElements":[{"name":"Trigger","spans":[{"start":9,"end":13,"text":"to specific checkpoint inhibitors"}]}]}]},{"target":{"name":"Judgment_communication","spans":[{"start":14,"end":15,"text":"critical"}]},"annotationSets":[{"rank":0,"score":92.48931222330539,"frameElements":[{"name":"Communicator","spans":[{"start":7,"end":13,"text":"clinical response to specific checkpoint inhibitors"}]},{"name":"Evaluee","spans":[{"start":15,"end":35,"text":"in order to stratify patients and to rationally select combinations in the context of an expanding array of therapeutic options"}]}]}]},{"target":{"name":"Choosing","spans":[{"start":23,"end":24,"text":"select"}]},"annotationSets":[{"rank":0,"score":33.10439163539722,"frameElements":[{"name":"Chosen","spans":[{"start":24,"end":25,"text":"combinations"}]}]}]},{"target":{"name":"Expansion","spans":[{"start":30,"end":31,"text":"expanding"}]},"annotationSets":[{"rank":0,"score":37.504903019530396,"frameElements":[{"name":"Item","spans":[{"start":31,"end":32,"text":"array"}]}]}]},{"target":{"name":"Diversity","spans":[{"start":31,"end":32,"text":"array"}]},"annotationSets":[{"rank":0,"score":14.368498752550412,"frameElements":[{"name":"Group","spans":[{"start":32,"end":35,"text":"of therapeutic options"}]}]}]},{"target":{"name":"Cure","spans":[{"start":33,"end":34,"text":"therapeutic"}]},"annotationSets":[{"rank":0,"score":46.42128084803626,"frameElements":[]}]},{"target":{"name":"Possibilities","spans":[{"start":34,"end":35,"text":"options"}]},"annotationSets":[{"rank":0,"score":17.676246638455144,"frameElements":[]}]}],"tokens":["The","identification","of","robust","biomarkers","that","predict","clinical","response","to","specific","checkpoint","inhibitors","is","critical","in","order","to","stratify","patients","and","to","rationally","select","combinations","in","the","context","of","an","expanding","array","of","therapeutic","options","."]}
{"frames":[{"target":{"name":"Means","spans":[{"start":0,"end":1,"text":"METHODS"}]},"annotationSets":[{"rank":0,"score":21.08232710714121,"frameElements":[{"name":"Means","spans":[{"start":0,"end":1,"text":"METHODS"}]}]}]}],"tokens":["METHODS","."]}
{"frames":[{"target":{"name":"Intentionally_act","spans":[{"start":1,"end":2,"text":"performed"}]},"annotationSets":[{"rank":0,"score":60.334300983620395,"frameElements":[{"name":"Act","spans":[{"start":2,"end":11,"text":"multiparameter flow cytometry on freshly isolated metastatic melanoma samples"}]},{"name":"Agent","spans":[{"start":0,"end":1,"text":"We"}]}]}]},{"target":{"name":"Fluidic_motion","spans":[{"start":3,"end":4,"text":"flow"}]},"annotationSets":[{"rank":0,"score":62.17228346739855,"frameElements":[]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":12,"end":13,"text":"2"}]},"annotationSets":[{"rank":0,"score":29.599240328643965,"frameElements":[{"name":"Number","spans":[{"start":12,"end":13,"text":"2"}]},{"name":"Entity","spans":[{"start":13,"end":14,"text":"cohorts"}]}]}]},{"target":{"name":"Aggregate","spans":[{"start":13,"end":14,"text":"cohorts"}]},"annotationSets":[{"rank":0,"score":29.711183496583338,"frameElements":[{"name":"Aggregate","spans":[{"start":13,"end":14,"text":"cohorts"}]}]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":15,"end":16,"text":"20"}]},"annotationSets":[{"rank":0,"score":31.384183298721197,"frameElements":[{"name":"Number","spans":[{"start":15,"end":16,"text":"20"}]},{"name":"Entity","spans":[{"start":16,"end":17,"text":"patients"}]}]}]},{"target":{"name":"Relative_time","spans":[{"start":18,"end":19,"text":"prior"}]},"annotationSets":[{"rank":0,"score":17.40791482823459,"frameElements":[{"name":"Focal_occasion","spans":[{"start":13,"end":17,"text":"cohorts of 20 patients"}]},{"name":"Landmark_occasion","spans":[{"start":18,"end":21,"text":"prior to treatment"}]}]}]},{"target":{"name":"Cure","spans":[{"start":20,"end":21,"text":"treatment"}]},"annotationSets":[{"rank":0,"score":47.05602779734238,"frameElements":[]}]},{"target":{"name":"Relative_time","spans":[{"start":24,"end":25,"text":"subsequent"}]},"annotationSets":[{"rank":0,"score":18.54238681386274,"frameElements":[]}]},{"target":{"name":"Response","spans":[{"start":26,"end":27,"text":"response"}]},"annotationSets":[{"rank":0,"score":40.071396614594654,"frameElements":[{"name":"Trigger","spans":[{"start":27,"end":32,"text":"with the tumor immune phenotype"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":29,"end":30,"text":"tumor"}]},"annotationSets":[{"rank":0,"score":31.409946575682167,"frameElements":[]}]}],"tokens":["We","performed","multiparameter","flow","cytometry","on","freshly","isolated","metastatic","melanoma","samples","from","2","cohorts","of","20","patients","each","prior","to","treatment","and","correlated","the","subsequent","clinical","response","with","the","tumor","immune","phenotype","."]}
{"frames":[{"target":{"name":"Causation","spans":[{"start":0,"end":1,"text":"RESULTS"}]},"annotationSets":[{"rank":0,"score":68.9285808599603,"frameElements":[]}]}],"tokens":["RESULTS","."]}
{"frames":[{"target":{"name":"Change_position_on_a_scale","spans":[{"start":0,"end":1,"text":"Increasing"}]},"annotationSets":[{"rank":0,"score":114.35317672478445,"frameElements":[]}]},{"target":{"name":"Building_subparts","spans":[{"start":4,"end":5,"text":"cell"}]},"annotationSets":[{"rank":0,"score":15.826701964257127,"frameElements":[{"name":"Building_part","spans":[{"start":4,"end":5,"text":"cell"}]}]}]},{"target":{"name":"Death","spans":[{"start":5,"end":6,"text":"death"}]},"annotationSets":[{"rank":0,"score":49.1396528668069,"frameElements":[]}]},{"target":{"name":"Cardinal_numbers","spans":[{"start":11,"end":12,"text":"4"}]},"annotationSets":[{"rank":0,"score":28.98209826758272,"frameElements":[{"name":"Number","spans":[{"start":11,"end":12,"text":"4"}]},{"name":"Entity","spans":[{"start":12,"end":13,"text":"high"}]}]}]},{"target":{"name":"Dimension","spans":[{"start":12,"end":13,"text":"high"}]},"annotationSets":[{"rank":0,"score":17.79232117842126,"frameElements":[{"name":"Dimension","spans":[{"start":12,"end":13,"text":"high"}]}]}]},{"target":{"name":"Building_subparts","spans":[{"start":23,"end":24,"text":"cells"}]},"annotationSets":[{"rank":0,"score":20.229340234165125,"frameElements":[{"name":"Building_part","spans":[{"start":23,"end":24,"text":"cells"}]}]}]},{"target":{"name":"Building_subparts","spans":[{"start":32,"end":33,"text":"cell"}]},"annotationSets":[{"rank":0,"score":16.01539625589215,"frameElements":[{"name":"Building_part","spans":[{"start":32,"end":33,"text":"cell"}]}]}]},{"target":{"name":"Taking_time","spans":[{"start":33,"end":34,"text":"subset"}]},"annotationSets":[{"rank":0,"score":26.184827121967526,"frameElements":[]}]},{"target":{"name":"Response","spans":[{"start":37,"end":38,"text":"response"}]},"annotationSets":[{"rank":0,"score":40.84155862681266,"frameElements":[]}]},{"target":{"name":"Cure","spans":[{"start":39,"end":40,"text":"therapy"}]},"annotationSets":[{"rank":0,"score":43.56857046402628,"frameElements":[]}]},{"target":{"name":"Surviving","spans":[{"start":45,"end":46,"text":"survival"}]},"annotationSets":[{"rank":0,"score":14.62601581185001,"frameElements":[]}]}],"tokens":["Increasing","fractions","of","programmed","cell","death","1","high/cytotoxic","T","lymphocyte-associated","protein","4","high","-LRB-","PD-1","-LRB-","hi","-RRB-","CTLA-4","-LRB-","hi","-RRB-","-RRB-","cells","within","the","tumor-infiltrating","CD8","-LRB-","+","-RRB-","T","cell","subset","strongly","correlated","with","response","to","therapy","-LRB-","RR","-RRB-","and","progression-free","survival","-LRB-","PFS","-RRB-","."]}
{"frames":[{"target":{"name":"Being_operational","spans":[{"start":0,"end":1,"text":"Functional"}]},"annotationSets":[{"rank":0,"score":8.014156762448048,"frameElements":[]}]},{"target":{"name":"Scrutiny","spans":[{"start":1,"end":2,"text":"analysis"}]},"annotationSets":[{"rank":0,"score":48.5207881054546,"frameElements":[{"name":"Manner","spans":[{"start":0,"end":1,"text":"Functional"}]},{"name":"Ground","spans":[{"start":2,"end":5,"text":"of these cells"}]}]}]},{"target":{"name":"Building_subparts","spans":[{"start":4,"end":5,"text":"cells"}]},"annotationSets":[{"rank":0,"score":25.639044266401946,"frameElements":[{"name":"Building_part","spans":[{"start":4,"end":5,"text":"cells"}]}]}]},{"target":{"name":"Evidence","spans":[{"start":5,"end":6,"text":"revealed"}]},"annotationSets":[{"rank":0,"score":40.65806792878742,"frameElements":[{"name":"Proposition","spans":[{"start":6,"end":12,"text":"a partially exhausted T cell phenotype"}]},{"name":"Support","spans":[{"start":0,"end":5,"text":"Functional analysis of these cells"}]}]}]},{"target":{"name":"Biological_urge","spans":[{"start":8,"end":9,"text":"exhausted"}]},"annotationSets":[{"rank":0,"score":35.151547797982346,"frameElements":[{"name":"Experiencer","spans":[{"start":0,"end":5,"text":"Functional analysis of these cells"}]}]}]},{"target":{"name":"Building_subparts","spans":[{"start":10,"end":11,"text":"cell"}]},"annotationSets":[{"rank":0,"score":15.617263796902979,"frameElements":[{"name":"Building_part","spans":[{"start":10,"end":11,"text":"cell"}]}]}]}],"tokens":["Functional","analysis","of","these","cells","revealed","a","partially","exhausted","T","cell","phenotype","."]}
{"frames":[{"target":{"name":"Assessing","spans":[{"start":0,"end":1,"text":"Assessment"}]},"annotationSets":[{"rank":0,"score":92.45296516875351,"frameElements":[{"name":"Assessor","spans":[{"start":0,"end":1,"text":"Assessment"}]},{"name":"Phenomenon","spans":[{"start":1,"end":4,"text":"of metastatic lesions"}]}]}]},{"target":{"name":"Cure","spans":[{"start":6,"end":7,"text":"therapy"}]},"annotationSets":[{"rank":0,"score":40.0541743545111,"frameElements":[]}]},{"target":{"name":"Reasoning","spans":[{"start":7,"end":8,"text":"demonstrated"}]},"annotationSets":[{"rank":0,"score":44.82469533689498,"frameElements":[{"name":"Content","spans":[{"start":8,"end":14,"text":"a release of T cell exhaustion"}]},{"name":"Arguer","spans":[{"start":0,"end":7,"text":"Assessment of metastatic lesions during anti-PD-1 therapy"}]}]}]},{"target":{"name":"Releasing","spans":[{"start":9,"end":10,"text":"release"}]},"annotationSets":[{"rank":0,"score":24.96854346088295,"frameElements":[{"name":"Agent","spans":[{"start":0,"end":7,"text":"Assessment of metastatic lesions during anti-PD-1 therapy"}]},{"name":"Theme","spans":[{"start":10,"end":14,"text":"of T cell exhaustion"}]}]}]},{"target":{"name":"Building_subparts","spans":[{"start":12,"end":13,"text":"cell"}]},"annotationSets":[{"rank":0,"score":15.893095290495852,"frameElements":[{"name":"Building_part","spans":[{"start":12,"end":13,"text":"cell"}]}]}]},{"target":{"name":"Biological_urge","spans":[{"start":13,"end":14,"text":"exhaustion"}]},"annotationSets":[{"rank":0,"score":36.725453759302574,"frameElements":[]}]},{"target":{"name":"Quantity","spans":[{"start":16,"end":17,"text":"measured"}]},"annotationSets":[{"rank":0,"score":18.070275044511224,"frameElements":[]}]},{"target":{"name":"Change_operational_state","spans":[{"start":22,"end":23,"text":"activated"}]},"annotationSets":[{"rank":0,"score":32.99239947514182,"frameElements":[]}]},{"target":{"name":"Building_subparts","spans":[{"start":28,"end":29,"text":"cells"}]},"annotationSets":[{"rank":0,"score":19.839948129755406,"frameElements":[{"name":"Building_part","spans":[{"start":28,"end":29,"text":"cells"}]}]}]},{"target":{"name":"Medical_conditions","spans":[{"start":30,"end":31,"text":"tumors"}]},"annotationSets":[{"rank":0,"score":36.396816614044745,"frameElements":[]}]},{"target":{"name":"Quantity","spans":[{"start":33,"end":34,"text":"no"}]},"annotationSets":[{"rank":0,"score":25.178121653222533,"frameElements":[{"name":"Quantity","spans":[{"start":33,"end":34,"text":"no"}]}]}]},{"target":{"name":"Objective_influence","spans":[{"start":34,"end":35,"text":"effect"}]},"annotationSets":[{"rank":0,"score":34.476860648016725,"frameElements":[{"name":"Dependent_entity","spans":[{"start":35,"end":37,"text":"on Tregs"}]}]}]}],"tokens":["Assessment","of","metastatic","lesions","during","anti-PD-1","therapy","demonstrated","a","release","of","T","cell","exhaustion",",","as","measured","by","an","accumulation","of","highly","activated","CD8","-LRB-","+","-RRB-","T","cells","within","tumors",",","with","no","effect","on","Tregs","."]}
{"frames":[{"target":{"name":"Coming_to_believe","spans":[{"start":0,"end":1,"text":"CONCLUSIONS"}]},"annotationSets":[{"rank":0,"score":33.87410545642198,"frameElements":[]}]}],"tokens":["CONCLUSIONS","."]}
{"frames":[{"target":{"name":"Statement","spans":[{"start":2,"end":3,"text":"suggest"}]},"annotationSets":[{"rank":0,"score":123.69323143563946,"frameElements":[{"name":"Message","spans":[{"start":3,"end":22,"text":"that the relative abundance of partially exhausted tumor-infiltrating CD8 -LRB- + -RRB- T cells predicts response to anti-PD-1 therapy"}]}]}]},{"target":{"name":"Kinship","spans":[{"start":5,"end":6,"text":"relative"}]},"annotationSets":[{"rank":0,"score":19.54857461649483,"frameElements":[]}]},{"target":{"name":"Quantity","spans":[{"start":6,"end":7,"text":"abundance"}]},"annotationSets":[{"rank":0,"score":21.375876310056814,"frameElements":[{"name":"Quantity","spans":[{"start":6,"end":7,"text":"abundance"}]}]}]},{"target":{"name":"Biological_urge","spans":[{"start":9,"end":10,"text":"exhausted"}]},"annotationSets":[{"rank":0,"score":34.865483153779216,"frameElements":[]}]},{"target":{"name":"Building_subparts","spans":[{"start":16,"end":17,"text":"cells"}]},"annotationSets":[{"rank":0,"score":21.163746289222676,"frameElements":[{"name":"Building_part","spans":[{"start":16,"end":17,"text":"cells"}]}]}]},{"target":{"name":"Expectation","spans":[{"start":17,"end":18,"text":"predicts"}]},"annotationSets":[{"rank":0,"score":35.294836960573704,"frameElements":[{"name":"Cognizer","spans":[{"start":4,"end":17,"text":"the relative abundance of partially exhausted tumor-infiltrating CD8 -LRB- + -RRB- T cells"}]},{"name":"Phenomenon","spans":[{"start":18,"end":22,"text":"response to anti-PD-1 therapy"}]}]}]},{"target":{"name":"Response","spans":[{"start":18,"end":19,"text":"response"}]},"annotationSets":[{"rank":0,"score":44.37295501610374,"frameElements":[{"name":"Trigger","spans":[{"start":19,"end":22,"text":"to anti-PD-1 therapy"}]}]}]},{"target":{"name":"Cure","spans":[{"start":21,"end":22,"text":"therapy"}]},"annotationSets":[{"rank":0,"score":40.0541743545111,"frameElements":[]}]}],"tokens":["Our","data","suggest","that","the","relative","abundance","of","partially","exhausted","tumor-infiltrating","CD8","-LRB-","+","-RRB-","T","cells","predicts","response","to","anti-PD-1","therapy","."]}
{"frames":[{"target":{"name":"Information","spans":[{"start":1,"end":2,"text":"information"}]},"annotationSets":[{"rank":0,"score":27.09864061081194,"frameElements":[{"name":"Information","spans":[{"start":1,"end":2,"text":"information"}]}]}]},{"target":{"name":"Likelihood","spans":[{"start":2,"end":3,"text":"can"}]},"annotationSets":[{"rank":0,"score":34.702354275061836,"frameElements":[{"name":"Hypothetical_event","spans":[{"start":0,"end":2,"text":"This information"}]}]}]},{"target":{"name":"Using","spans":[{"start":4,"end":5,"text":"used"}]},"annotationSets":[{"rank":0,"score":113.69496291739372,"frameElements":[{"name":"Instrument","spans":[{"start":0,"end":2,"text":"This information"}]},{"name":"Purpose","spans":[{"start":5,"end":22,"text":"to appropriately select patients with a high likelihood of achieving a clinical response to PD-1 pathway inhibition"}]}]}]},{"target":{"name":"Choosing","spans":[{"start":7,"end":8,"text":"select"}]},"annotationSets":[{"rank":0,"score":33.64323364689062,"frameElements":[{"name":"Chosen","spans":[{"start":8,"end":9,"text":"patients"}]}]}]},{"target":{"name":"Position_on_a_scale","spans":[{"start":11,"end":12,"text":"high"}]},"annotationSets":[{"rank":0,"score":20.24871716833441,"frameElements":[{"name":"Item","spans":[{"start":13,"end":22,"text":"of achieving a clinical response to PD-1 pathway inhibition"}]},{"name":"Value","spans":[{"start":11,"end":12,"text":"high"}]}]}]},{"target":{"name":"Likelihood","spans":[{"start":12,"end":13,"text":"likelihood"}]},"annotationSets":[{"rank":0,"score":30.576541032858593,"frameElements":[{"name":"Hypothetical_event","spans":[{"start":13,"end":22,"text":"of achieving a clinical response to PD-1 pathway inhibition"}]}]}]},{"target":{"name":"Accomplishment","spans":[{"start":14,"end":15,"text":"achieving"}]},"annotationSets":[{"rank":0,"score":54.553697849252565,"frameElements":[{"name":"Goal","spans":[{"start":18,"end":22,"text":"to PD-1 pathway inhibition"}]}]}]},{"target":{"name":"Response","spans":[{"start":17,"end":18,"text":"response"}]},"annotationSets":[{"rank":0,"score":42.4909951775915,"frameElements":[{"name":"Trigger","spans":[{"start":18,"end":22,"text":"to PD-1 pathway inhibition"}]}]}]},{"target":{"name":"Roadways","spans":[{"start":20,"end":21,"text":"pathway"}]},"annotationSets":[{"rank":0,"score":67.9518304484395,"frameElements":[{"name":"Roadway","spans":[{"start":20,"end":21,"text":"pathway"}]}]}]}],"tokens":["This","information","can","be","used","to","appropriately","select","patients","with","a","high","likelihood","of","achieving","a","clinical","response","to","PD-1","pathway","inhibition","."]}
